Status | Study |
RECRUITING |
Study Name: Glycemic Control, Type II Diabetes, Parathyroidectomy Condition: Primary Hyperparathyroidism Date: 2023-02-28 Interventions: Urine N-telopeptide and serum osteocalcin |
Completed |
Study Name: Effect of Mechanical Loading on vBMD and Geometry in Patients With Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2022-06-10 Interventions: Not Provided |
Recruiting |
Study Name: Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2017-02-10 Interventions: Other: Retrospective Data Review Retrospective, uncontrolled pre- and post-test design in a case series |
Recruiting |
Study Name: Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism Condition: Parathyroid Gland Adenoma Primary Hyperparathyroidism Date: 2017-01-04 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Effect of Parathyroidectomy on Cardiovascular Health Condition: Primary Hyperparathyroidism Date: 2016-12-02 Interventions: Procedure: Early parathyroidectomy group (EPTX-group) Participants will undergo parathyroidectomy as soo |
Recruiting |
Study Name: Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2015-08-14 Interventions: Drug: eplerenone eplerenone, t |
Completed |
Study Name: Bone Architectural Parameters in Postmenopausal Women Affected With Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Bone Disease Date: 2015-04-27 Interventions: Device: HR-pQCT HR-pQCT to evaluate cortical and trabecular bone |
Recruiting |
Study Name: Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions? Condition: Primary Hyperparathyroidism Date: 2014-08-17 Interventions: Drug: Cinacalcet Cinacalcet, M |
Recruiting |
Study Name: EC17 for Intraoperative Imaging for Parathyroidectomy Condition: Primary Hyperparathyroidism Date: 2013-11-21 Interventions: Drug: EC17 Other Name: Folate- FITC |
Completed |
Study Name: OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2013-06-21 Interventions: Drug: Sedron (alendronate) Oth |